Mass Spectrometry-Based Omics for the Characterization of Triple-Negative Breast Cancer Bio-Signature

Triple-negative breast cancer (TNBC) represents an unmet medical need due to a high rate of metastatic occurrence and poor overall survival, pathology aggressiveness, heterogeneous clinical behavior and limited cytotoxic chemotherapy options available because of the absence of targetable receptors....

Descripción completa

Detalles Bibliográficos
Autores principales: Pralea, Ioana-Ecaterina, Moldovan, Radu-Cristian, Țigu, Adrian-Bogdan, Ionescu, Corina, Iuga, Cristina-Adela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768464/
https://www.ncbi.nlm.nih.gov/pubmed/33322818
http://dx.doi.org/10.3390/jpm10040277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768464/
https://www.ncbi.nlm.nih.gov/pubmed/33322818
http://dx.doi.org/10.3390/jpm10040277

Ejemplares similares